Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Non Operating Income (2016 - 2025)

Amphastar Pharmaceuticals (AMPH) has 13 years of Non Operating Income data on record, last reported at $1.0 million in Q4 2025.

  • For Q4 2025, Non Operating Income rose 115.71% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $522000.0, up 103.33%, while the annual FY2025 figure was $522000.0, 103.33% up from the prior year.
  • Non Operating Income reached $1.0 million in Q4 2025 per AMPH's latest filing, down from $8.8 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $13.3 million in Q3 2021 and bottomed at -$9.4 million in Q3 2024.
  • Average Non Operating Income over 5 years is $205950.0, with a median of -$262000.0 recorded in 2023.
  • Peak YoY movement for Non Operating Income: soared 647.31% in 2023, then crashed 4699.25% in 2025.
  • A 5-year view of Non Operating Income shows it stood at $2.9 million in 2021, then grew by 17.8% to $3.4 million in 2022, then crashed by 259.92% to -$5.5 million in 2023, then decreased by 17.73% to -$6.5 million in 2024, then skyrocketed by 115.71% to $1.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were $1.0 million in Q4 2025, $8.8 million in Q3 2025, and -$2.8 million in Q2 2025.